| Literature DB >> 27720608 |
Zhiqiang Lin1, Haidong Guo2, Yuan Cao3, Sylvia Zohrabian4, Pingzhu Zhou4, Qing Ma4, Nathan VanDusen4, Yuxuan Guo4, Jin Zhang4, Sean M Stevens4, Feng Liang5, Qimin Quan5, Pim R van Gorp6, Amy Li7, Cristobal Dos Remedios7, Aibin He8, Vassilios J Bezzerides4, William T Pu9.
Abstract
Binding of the transcriptional co-activator YAP with the transcription factor TEAD stimulates growth of the heart and other organs. YAP overexpression potently stimulates fetal cardiomyocyte (CM) proliferation, but YAP's mitogenic potency declines postnatally. While investigating factors that limit YAP's postnatal mitogenic activity, we found that the CM-enriched TEAD1 binding protein VGLL4 inhibits CM proliferation by inhibiting TEAD1-YAP interaction and by targeting TEAD1 for degradation. Importantly, VGLL4 acetylation at lysine 225 negatively regulated its binding to TEAD1. This developmentally regulated acetylation event critically governs postnatal heart growth, since overexpression of an acetylation-refractory VGLL4 mutant enhanced TEAD1 degradation, limited neonatal CM proliferation, and caused CM necrosis. Our study defines an acetylation-mediated, VGLL4-dependent switch that regulates TEAD stability and YAP-TEAD activity. These insights may improve targeted modulation of TEAD-YAP activity in applications from cardiac regeneration to cancer.Entities:
Keywords: Hippo-YAP pathway; TEAD1; VGLL4; acetylation; cardiac; cardiomyocyte; degradation; necrosis; proliferation
Mesh:
Substances:
Year: 2016 PMID: 27720608 PMCID: PMC5121000 DOI: 10.1016/j.devcel.2016.09.005
Source DB: PubMed Journal: Dev Cell ISSN: 1534-5807 Impact factor: 12.270